inveox inveox is a biotechnology company that develops systems to digitize, automate, and connect pathology laboratories. | ![]() A28 Therapeutics A28 Therapeutics is a biopharmaceutical company focused on the development of a targeted oncolytic peptide platform for the treatment of multiple cancer types. | ![]() Immunovia Immunovia engages in the development of a technology platform based on antibody microarray analysis. | bioAffinity Technologies bioAffinity Technologies is a company focusing on the diagnosis of early-stage cancer, diseases of the lung, and targeted cancer treatment. | ||
Founding Date | Founding Date 2017 | Founding Date 2021 | Founding Date 2014 | Founding Date 2007 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Garching bei München, DE HQ Kraków, PL Houston, US | Locations La Jolla, US HQ | Locations South San Francisco, US HQ | Locations Lund, SE HQ Lund, SE Marlborough, US | Locations San Antonio, US HQ San Antonio, US |
Employees | Employees 9 | Employees 7 | Employees 4172% increase | Employees 9 | Employees 11 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 10.2 m | Valuation ($) 21.1 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr685k (FY, 2025) | Revenue (est.) $6.2m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income (kr145.9m) (FY, 2025) | Net income ($14.9m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 507.6m | Total funding raised $ 5.2m | Total funding raised $ 4.2m |

A28 Therapeutics is a biopharmaceutical company focused on the development of a targeted oncolytic peptide platform for the treatment of multiple cancer types.
View companyFreenome is a biotech company that develops blood tests to detect cancer.
View company
Immunovia engages in the development of a technology platform based on antibody microarray analysis.
View companybioAffinity Technologies is a company focusing on the diagnosis of early-stage cancer, diseases of the lung, and targeted cancer treatment.
View company